Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology.

[1]  J. Vacanti,et al.  Differentiation of human bone marrow mesenchymal stem cells on decellularized extracellular matrix materials. , 2014, Journal of biomedical materials research. Part A.

[2]  S. Giannini,et al.  A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate , 2014, Journal of tissue engineering and regenerative medicine.

[3]  Lei Chen,et al.  Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice , 2014, PloS one.

[4]  P. Hernigou,et al.  Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells , 2013, International Orthopaedics.

[5]  S. Giannini,et al.  The posterior iliac crest outperforms the anterior iliac crest when obtaining mesenchymal stem cells from bone marrow. , 2013, The Journal of bone and joint surgery. American volume.

[6]  H. Northoff,et al.  Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.

[7]  R. Casaburi,et al.  A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. , 2013, Chest.

[8]  Y. Rui,et al.  Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors , 2013, Stem Cell Research & Therapy.

[9]  T. Olson,et al.  Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. , 2013, Cytotherapy.

[10]  Daniel-Christoph Wagner,et al.  Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield , 2012, PloS one.

[11]  S. Messinger,et al.  Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. , 2012, JAMA.

[12]  K Sritharan,et al.  Tracheobronchial transplantation with a bioartifical nanocomposite , 2012, Thorax.

[13]  Staffan Strömblad,et al.  RETRACTED: Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study , 2011, The Lancet.

[14]  Narutoshi Hibino,et al.  Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. , 2011, Tissue engineering. Part C, Methods.

[15]  J. Vacanti,et al.  The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. , 2010, Biomaterials.

[16]  Joseph P Vacanti,et al.  Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. , 2010, Biomaterials.

[17]  R. Schmelzeisen,et al.  In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method. , 2010, Tissue engineering. Part C, Methods.

[18]  E. Seifried,et al.  Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. , 2010, Journal of the American College of Cardiology.

[19]  Clemens A van Blitterswijk,et al.  The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells , 2009, Acta orthopaedica.

[20]  M. Baker.  Stem-cell drug fails crucial trials , 2009 .

[21]  V. Velebný,et al.  Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets , 2008, Cell biology international.

[22]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[23]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[24]  C. Heeschen,et al.  Concentration of Bone Marrow Total Nucleated Cells by a Point-of-Care Device Provides a High Yield and Preserves Their Functional Activity , 2007, Cell transplantation.

[25]  V. Falanga,et al.  Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.

[26]  H. Fujioka,et al.  Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. , 2007, Osteoarthritis and cartilage.

[27]  G. Dini,et al.  Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease. , 2006 .

[28]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[29]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.

[30]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[31]  Elizabeth Simpson,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[32]  R. Cancedda,et al.  Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. , 2002, Tissue engineering.

[33]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Hung Li,et al.  Isolation and Characterization of Size‐Sieved Stem Cells from Human Bone Marrow , 2002, Stem cells.

[35]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[36]  C. Heeschen,et al.  Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. , 2008, Cell transplantation.

[37]  A. Germing.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction , 2007 .

[38]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[39]  Sergio Romagnani,et al.  Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. , 2006, Stem cells.

[40]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[41]  G. Pizzolo,et al.  Role for IFN-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells , 2005 .